ArticleJAMA internal medicine2025
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.
Sara Wing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleJAMA internal medicine2025
Sara Wing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.